Summary
The kinetics of absorption, of changes in blood concentration, and of biliary excretion after the i.v. and i.d. administration of 40 μCi each, of digoxin, 4‴-acetyldigoxin and 4‴-methyldigoxin were studied in biliary fistula rats. The highest blood concentrations were found after the i.v. administration of 4‴-methyldigoxin, which decline with a half life time of 10 h, compared with 5.6 and 4.5 h for 4‴-acetyldigoxin and digoxin respectively. 71%, 55% and 17% of the dose were excreted in the bile within 12 h after the i.v. administration of digoxin, 4‴-acetyldigoxin and 4‴-methyldigoxin. The blood concentrations observed after the i.d. administration of digoxin and 4‴-acetyldigoxin show almost identical pharmacokinetics with respect to height and elimination velocity (half life 7.0 h for digoxin and 7.5 h for 4‴-acetyldigoxin). In contrast, following the i.d.administration of 4‴-methyldigoxin, blood concentrations, which were twice as high, were observed and declined with the same half life as after the i.v. administration.
Determination of the disappearance rates of these glycosides from the intestinal lumen reveals a biphasic course of absorption. A first phase, with k values of 0.4, 0.5, 1.2 for digoxin, 4‴-acetyldigoxin and 4‴-methyldigoxin respectively is followed by a second phase with k values of 0.04, 0.04, 0.001 for digoxin, 4‴-acetyldigoxin and 4‴-methyldigoxin. Thus, 4‴-methyldigoxin is almost completely absorbed within the first two hours, while digoxin and 4‴-acetyldigoxin continue to be absorbed during the following hours. The absorption velocity of digoxin from the ileum was found to be one half of that seen in the duodenum. But this slow absorption, as well, follows a biphasic course.
The data indicate that 4‴-methyldigoxin is absorbed at a distinctly higher rate than 4‴-acetyldigoxin and digoxin. Acetylation in 4‴ position evidently provides no important advantage with respect to absorption. While this study allows the determination of absorption and excretion velocities, no account of absorption quotes is given.
Similar content being viewed by others
References
Abshagen, U., Bergmann, K. V., Rietbrock, N.: Evaluation of Enterohepatic, Circulation after Digoxin Administration in Rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 1972 (in press).
Bergmann, K. v., Abshagen, U., Rietbrock, N.: Quantitative analyis of digoxin, 4‴-acetyldigoxin and 4‴-methyldigoxin and their metabolites in bile and urine of rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 273, 154–167 (1972).
Fisher, R. B., Parsons, D. S.: The gradient of mucosal surface in the small intestine of the rat. J. Anat. (Lond.) 84, 272–282 (1950).
Forth, W., Furukawa, E., Rummel, W., unter Mitarbeit von Anders, H.: Intestinale Resorption von Herzglykosiden in vitro und in vivo. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 262, 53–72 (1969a).
unter Mitarbeit von Anders, H.: Die Bestimmung der intestinalen Resorption von Herzglykosiden durch Messung der 3H-markierten Glykoside im Portalvenenblut und in der Darmlymphe bei Katzen. Naunyn-Schmiedebergs Arch. Pharmak. 264, 406–419 (1969b).
Greenberger, N. J., Mac Dermott, R. P., Maertin, J. F., Dutta, S.: Intestinal absorption of six tritium labeled digitalis glycosides in rats and guinea pigs. J. Pharmacol. exp. Ther. 167, 265–273 (1969).
Haberland, G.: Darstellung und Eigenschaften von Glykosidestern. Arzneimittel-Forsch. (Drug-Res.) 15, 481–483 (1965)
Herrmann, J., Repke, K.: Entgiftungsgeschwindigkeit und Kumulation von Digitoxin bei verschiedenen Species. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 247, 19–34 (1964).
Kaiser, F.: Teilsynthetische Herzglykosid-Derivate mit verbesserter enteraler Wirksamkeit. 28. Mitteilung über Herzglykoside. Planta Medica 20, Suppl. 4, 52–60 (1971).
Lauterbach, F.: Comparison of intestinal penetration of cortisol and convallatoxin: demonstration of a transport mechanism for cardiotonic steroids. Biochim. biophys. Acta (Amst.) 150, 146–155 (1968).
: Die enterale Sekretion kardiotoner Steroide — Untersuchungen zum Mechanismus des Resorptionsvorgangs. Naunyn-Schmiedebergs Arch. Pharmak. 264, 267–268 (1968).
: Absorption of cardiac glycosides. Acta pharmacol. (Kbh.) 29, Suppl. 4, 80 (1971).
Lingner, K., Küssner, W.: Resorption und Abbau herzwirksamer Glykoside. Arzneimittel-Forsch. (Drug Res.) 12, 835–841 (1962).
Megges, S. R., Repke, K.: Über Faktoren, welche die orale Wirksamkeit von Herzglykosiden bestimmen. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 241, 534 (1961).
Rennekamp, H., Rennekamp, Ch., Abshagen, U., Bergmann, K. v., Rietbrock, N.: Pharmacokinetical behaviour of 4‴-methyldigoxin in man. Naunyn-Schmiedeberg's Arch. Pharmacol. 273, 172–174 (1972).
Repke, K.: Stoffwechsel und Wirkung von Digitalisglykosiden. Öst. Apoth.-Ztg 24, 515–522 (1970).
, Est, M., Portius, H. J.: Über die Ursache der Speciesunterschiede in der Digitalisempfindlichkeit. Biochem. Pharmacol. 14, 1785–1802 (1965).
Rietbrock, N., Abshagen, U., Bergmann, K. v.: Rationelle Therapie mit Digoxin und Derivaten. Grundlagen der Therapie. In: Symposion „Herzinsuffizienz”, Hamburg 1972. Boehringer-Schriftenreihe.
Schaumann, W., Zielske, F., Kohler, K., Koch, K.: β-Methyl-Digoxin. III. Speed of absorption in guinea-pigs in comparison to other cardiac glycosides. Naunyn-Schmiedeberg's Arch. Pharmacol. 272, 32–45 (1972).
Voigtländer, W., Schaumann, W., Koch, K., Zielske, F.: β-Methyl-Digoxin. IV. Blood levels, tissue distribution and metabolism in the guinea-pig. Naunyn-Schmiedeberg's Arch. Pharmacol. 272, 46–64 (1972).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rietbrock, N., Abshagen, U., Bergmann, K.v. et al. Pharmacokinetics of digoxin and its 4‴-acetyl-and methylderivates in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 171–181 (1972). https://doi.org/10.1007/BF00501851
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00501851